News Detail
Bristol, 10 Dec 2023: Currently, there are limited antiviral therapies available against SARS-CoV-2 - the virus that causes COVID-19, and these drugs are not always effective, highlighting the need for more treatments. Also, the virus can mutate, and its variants can become parti......
View Details
Source : University of Bristol
SARS-CoV-2
MERS-CoV
HCoV-229E
Drug repurposing
Cobicistat
Antivirals
Related News
- Genetic testing could lower the risk of adverse drug reactions with cancer (05-11-2024)
- Use of pluripotent stem cells successfully treats type 1 diabetes: study (04-11-2024)
- KU gets patent for new wound-healing dressing for diabetic patients (30-10-2024)
- New bacterial toxins discovered: A key to fighting infections (23-10-2024)
- Thyme shows promise as natural antibiotic, finds IICT-Dambi varsity study (10-10-2024)
- Researchers Introduce Algorithm to Detect Drug Interactions at JSM Conference (07-10-2024)
- Chinese woman finds type 1 diabetes reversed after stem cell transplant in world first (01-10-2024)
- NIAB scientists develop diagnostic kit to detect antibiotics in animal food samples (22-09-2024)
- Cancer cells may be using lipids to hide from the immune system (19-09-2024)
- Study links personal care products to increased hormonal disruptions in children (15-09-2024)